Mealey's (April 25, 2023, 8:45 AM EDT) -- WASHINGTON, D.C. — The company that makes Tepezza tells the Judicial Panel on Multidistrict Litigation (JPMDL) that it should deny a plaintiff’s motion to centralize federal hearing loss cases in a multidistrict litigation, saying the drug’s label warns of the risk and that there are too few cases....